From the results obtained, we concluded that the treatment of NAFLD with MERTK+/hi M2c macrophages can modulate lipid homeostasis by increasing the level of HDL secretion in the liver, which could counter the bad influence of vLDL/LDL. The gene discussed is MERTK; the disease is metabolic dysfunction-associated steatotic liver disease.